Jason S. Lewis, PhD

My research interests are focused on the development of new PET radiopharmaceuticals for the diagnosis and treatment of cancer. My work incorporates ⁸⁹Zr, ¹⁸F, ¹¹C, and other nonstandard nuclides, with an emphasis on designing novel PET agents for cancer imaging. My research program is a molecular-imaging-based program focused on the targetry of nonstandard nuclides as well as the development of small and biomolecule-based agents and their clinical translation. I have worked on the development of small molecules targeting cancer, as well as radiolabeled peptides and ⁸⁹Zr-labeled antibodies targeting the overexpression of receptors and antigens on tumors. The research is supported by the National Institutes of Health, the Department of Education, and philanthropy.

I am also principle investigator (PI) of a “DOE Center of Excellence in Radiochemistry,” which supports junior faculty, postdoctoral, and graduate trainees. I am also a co-PI of an NSF IGERT grant with Hunter College of the City University of New York (CUNY) that will support 15 PhD candidates in radiochemistry.